Zheng, Xinhe https://orcid.org/0000-0002-4388-6724
Thompson, Patrick C. https://orcid.org/0009-0006-2755-2819
White, Cassandra M. https://orcid.org/0000-0002-6697-4321
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG012819)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH137042)
Simons Foundation (SFARI 736613)
Esther A. and Joseph Klingenstein Fund (Klingenstein-Simons Fellowship Award)
G. Harold and Leila Y. Mathers Foundation (Mathers Foundation Award)
Larry L. Hillblom Foundation (Start-up Award)
Pew Charitable Trusts (Pew Biomedical Scholar)
McKnight Endowment Fund for Neuroscience (McKnight Scholar)
Impetus grant, One Mind Rising Star Award, Scripps Collaborative Innovative Fund, Chan Zuckerberg Initiative, Conrad Prebys Foundation, Astera Institute, and James Fickel.
Dorris Scholar Award
Skaggs-Oxford Fellowship and The Schimmel Family Endowed Fellowship
Article History
Received: 21 July 2024
Accepted: 25 November 2024
First Online: 12 February 2025
Competing interests
: X.J. and X.Z. are co-inventors on in vivo AAV-based Perturb-seq and CRISPR inventions filed by Scripps Research relating to the work in this protocol. P.C.T. and C.M.W. declare no competing interests.